GlaxoSmithKline today announced the start of an international Phase III trial of its investigational cancer treatment Tykerb? (lapatinib) in squamous cell carcinoma of the head and neck (SCCHN).
Industry-funded studies of breast cancer therapies are more likely to report positive results than non-pharmaceutical funded studies, researchers from the University of North Carolina at Chapel Hill and the Dana Farber Cancer Institute have found.
Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.
Physicians caring for children with cancer should be on the lookout for signs of bone fragility caused by disease and treatment, according to a new report.
African and African American women are more likely to die of breast cancer than their white counterparts because they tend to get the disease before the menopause, suggests new research from the University of East Anglia and the Children’s Hospital Boston in collaboration with researchers in the US and Italy.
A breath test can successfully pick up lung cancer with “moderate accuracy” even in the early stages, reveals research published ahead of print in Thorax.
A researcher in the Oregon Health & Science University Cancer Institute and Portland Veterans Affairs Medical Center has found a way to identify which men need a second prostate biopsy because they may be harboring life-threatening prostate cancer even though they were given a clean bill of health after their first biopsy.
Genentech, Inc. (NYSE: DNA) announced that a Roche-sponsored Phase III study evaluating two different doses of Avastin(R) (bevacizumab) in combination with gemcitabine and cisplatin chemotherapy met the primary endpoint of prolonging progression-free survival (PFS) in patients with previously untreated, advanced non-squamous, non-small cell lung cancer (NSCLC), the most common form of the disease.
New figures published by Irish Life reveal that for the first time cancer has overtaken heart related illness as the number one cause of serious illness claims for men.
In an effort to reach a greater audience, and help patients and their families understand their cancer treatment options, the American Society for Therapeutic Radiology and Oncology now offers Spanish versions of their popular brochures Radiation Therapy for Breast Cancer and Radiation Therapy for Prostate Cancer.